Switch to:
PDL BioPharma Inc (NAS:PDLI)
Piotroski F-Score
3 (As of Today)

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PDL BioPharma Inc has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

PDLI' s 10-Year Piotroski F-Score Range
Min: 2   Max: 7
Current: 3

2
7

During the past 13 years, the highest Piotroski F-Score of PDL BioPharma Inc was 7. The lowest was 2. And the median was 4.


Definition

How is the Piotroski F-Score calculated?

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Dec14) TTM:Last Year (Dec13) TTM:
Net Income was 72.883 + 92.055 + 102.235 + 55.071 = $322.2 Mil.
Cash Flow from Operations was 91.779 + 54.374 + 77.086 + 69.042 = $292.3 Mil.
Revenue was 139.664 + 162.752 + 164.594 + 117.075 = $584.1 Mil.
Gross Profit was 127.733 + 162.752 + 164.594 + 117.075 = $572.2 Mil.
Average Total Assets from the begining of this year (Dec13)
to the end of this year (Dec14) was
(543.955 + 852.579 + 916.405 + 979.869 + 962.35) / 5 = $851.0316 Mil.
Total Assets at the begining of this year (Dec13) was $544.0 Mil.
Long-Term Debt was $276.2 Mil.
Total Current Assets was $355.9 Mil.
Total Current Liabilities was $188.0 Mil.
Net Income was 53.471 + 93.742 + 56.225 + 61.092 = $264.5 Mil.

Revenue was 91.847 + 143.617 + 97.314 + 110.143 = $442.9 Mil.
Gross Profit was 91.847 + 143.617 + 97.314 + 104.506 = $437.3 Mil.
Average Total Assets from the begining of last year (Dec12)
to the end of last year (Dec13) was
(279.966 + 312.81 + 401.424 + 429.672 + 543.955) / 5 = $393.5654 Mil.
Total Assets at the begining of last year (Dec12) was $280.0 Mil.
Long-Term Debt was $0.0 Mil.
Total Current Assets was $107.7 Mil.
Total Current Liabilities was $407.4 Mil.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PDL BioPharma Inc's current net income (TTM) was 322.2. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

PDL BioPharma Inc's current cash flow from operations (TTM) was 292.3. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year’s return on assets (1) to last year’s return on assets.

Score 1 if it’s higher, 0 if it’s lower.

ROA (This Year)=Net Income (TTM)/Total Assets at the Beginning of This Year (Dec13)
=322.244/543.955
=0.5924093

ROA (Last Year)=Net Income (TTM)/Total Assets at the Beginning of Last Year (Dec12)
=264.53/279.966
=0.94486473

PDL BioPharma Inc's return on assets of this year was 0.5924093. PDL BioPharma Inc's return on assets of last year was 0.94486473. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

PDL BioPharma Inc's current net income (TTM) was 322.2. PDL BioPharma Inc's current cash flow from operations (TTM) was 292.3. ==> 292.3 <= 322.2 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year’s gearing (long-term debt divided by average total assets) to last year’s gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec14)=Long-Term Debt/Average Total Assets from Dec13 to Dec14
=276.228/851.0316
=0.32458019

Gearing (Last Year: Dec13)=Long-Term Debt/Average Total Assets from Dec12 to Dec13
=0/393.5654
=0

PDL BioPharma Inc's gearing of this year was 0.32458019. PDL BioPharma Inc's gearing of last year was 0. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year’s current ratio (current assets divided by current liabilities) to last year’s current ratio.

Score 1 if this year'’s current ratio is higher, 0 if it’s lower

Current Ratio (This Year: Dec14)=Total Current Assets/Total Current Liabilities
=355.897/187.983
=1.89324035

Current Ratio (Last Year: Dec13)=Total Current Assets/Total Current Liabilities
=107.697/407.424
=0.26433642

PDL BioPharma Inc's current ratio of this year was 1.89324035. PDL BioPharma Inc's current ratio of last year was 0.26433642. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

PDL BioPharma Inc's number of shares in issue this year was 197. PDL BioPharma Inc's number of shares in issue last year was 171.3. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year’s gross margin (gross profit divided by sales) to last year’s.

Score 1 if this year’s gross margin is higher, 0 if it’s lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=572.154/584.085
=0.97957318

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=437.284/442.921
=0.98727313

PDL BioPharma Inc's gross margin of this year was 0.97957318. PDL BioPharma Inc's gross margin of last year was 0.98727313. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year’s asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year’s asset turnover ratio.

Score 1 if this year’s asset turnover ratio is higher, 0 if it’s lower

Asset Turnover (This Year)=Revenue (TTM)/Total Assets at the Beginning of This Year (Dec13)
=584.085/543.955
=1.07377449

Asset Turnover (Last Year)=Revenue (TTM)/Total Assets at the Beginning of Last Year (Dec12)
=442.921/279.966
=1.58205282

PDL BioPharma Inc's asset turnover of this year was 1.07377449. PDL BioPharma Inc's asset turnover of last year was 1.58205282. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+0+0+1+0+0+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

PDL BioPharma Inc has an F-score of 3. It is a bad or low score, which usually implies poor business operation.


Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Related Terms

Net Income, Cash Flow from Operations, Revenue, Gross Profit, Total Assets, Long-Term Debt, Total Current Assets, Total Current Liabilities


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

PDL BioPharma Inc Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
Question 1 0001111111
Question 2 1111111111
Question 3 0111101110
Question 4 1111010010
Question 5 0110011010
Question 6 0010011101
Question 7 0000011100
Question 8 0000000000
Question 9 1011101110
F-score 3465467663

PDL BioPharma Inc Quarterly Data

Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14
Question 1 1111111111
Question 2 1111111111
Question 3 1111110000
Question 4 1011111000
Question 5 0001111110
Question 6 1110000001
Question 7 1100000000
Question 8 0000000000
Question 9 0111110000
F-score 6666664333
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK